Table 5.
Gene expression analyses in CHD patients.
| Platform | Patients | Changes in Expression | Impact | Reference |
|---|---|---|---|---|
| Human Unigene Set-RZPD2 cDNA Array |
55 CHD | 88 dysregulated genes (e.g. SNIP, A2B1, KIAA1437) |
potential relevance for TOF | [76] |
| Applied Microarrays Inc. CodeLink Human Whole Genome Bioarray |
19 TOF | 1062 dysregulated genes (e.g. WNT and NOTCH pathway) |
potential relevance for TOF | [81] |
| Affymetrix Human Exon 1.0 ST v2 | 16 TOF |
NEFH, SST, TF, KRT6A, KRT7,NTRK2, MYL2, PPBP, NRGN, APOC3 |
dysregulated network in TOF | [84] |
| Affymetrix Human Exon 1.0 ST | 6 HLHS | 153 and 96 dysregulated genes vs. normal RV and LV, respectively |
potential relevance for HLHS | [87] |
| Affymetrix GeneChip microRNA 1.0 | 24 TOF | 61 dysregulated miRNAs | dysregulation of 44 cardiac genes in TOF |
[86] |
RV: right ventricle, LV: left ventricle.